会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明公开
    • NON-AQUEOUS PATCH
    • 非水性补丁
    • EP2708229A1
    • 2014-03-19
    • EP11865320.3
    • 2011-05-10
    • Itochu Chemical Frontier CorporationOishi Koseido Co., Ltd
    • MORI, TatsuyaSAIDA, Naoyuki
    • A61K31/167A61K9/70A61K47/10A61K47/12A61P23/00A61P29/00
    • A61K9/0014A61K9/7053A61K9/7076A61K31/167A61K47/10A61K47/12
    • Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore, non-aqueous patches have a high concentration of lidocaine. It is pointed out that lidocaine has an adverse effect on the heart. Prolonged use of a high concentration of lidocaine causes side effects, such as shock, rubor, and irritating sensation. External preparations comprising more than 5 mass% of lidocaine are designated as powerful drugs, and cannot be used as household (nonprescription) medicine. Provided is a non-aqueous patch that is effective to relieve muscle pain, the non-aqueous patch comprising lidocaine and/or its reactant, and a dissolving agent composed of an organic acid and a polyalcohol, which are contained in a base.
    • 包含利多卡因的非水性贴剂,其不溶解并且以结晶状态存在,对皮肤的渗透性差。 因此,非水性贴剂具有高浓度的利多卡因。 有人指出利多卡因对心脏有不良影响。 长时间使用高浓度的利多卡因引起副作用,如休克,红宝石和刺激性感觉。 包含超过5质量%的利多卡因的外用制剂被指定为强效药物,并且不能用作家庭(非处方)药物。 本发明提供可有效缓解肌肉疼痛的非水性贴剂,含有利多卡因和/或其反应物的非水性贴剂以及由有机酸和多元醇构成的溶解剂。
    • 75. 发明公开
    • TRANSDERMAL ABSORPTION PREPARATION
    • EP2561865A2
    • 2013-02-27
    • EP11772254.6
    • 2011-04-21
    • Icure Pharmaceutical Inc.
    • CHOI, Young KweonKIM, Jung JuKIM, Seong SuLEE, Jung SikPARK, Seong Min
    • A61K9/70A61K31/404A61P25/00
    • A61K9/7061A61K9/7053A61K9/7076A61K31/4045
    • The present invention relates to a transdermal absorption preparation. The transdermal absorption preparation of the present invention comprises a drug-containing adhesive layer, a drug-protective layer and a release layer, wherein the drug-containing adhesive layer contains ropinirole or a salt thereof, rubber, an adhesion-imparting resin, an antioxidant, and a transdermal absorption promoter. Also, the present invention provides a transdermal absorption preparation comprising a drug-containing adhesive layer, a drug-protective layer, and a release layer, wherein the drug-containing adhesive layer contains ropinirole or a salt thereof, acrylic rubber, an anti-crystallization agent, and a transdermal absorption promoter. When the transdermal absorption preparation of the present invention is used for the treatment of Parkinson's disease or restless leg syndrome, no side effect due to an increase in the initial drug concentration in blood occurs and the skin penetration effect of the drug is excellent.
    • 本发明涉及透皮吸收制剂。 本发明的透皮吸收制剂包含含药粘合剂层,药物保护层和释放层,其中含药粘合剂层含有罗匹尼罗或其盐,橡胶,粘合性树脂,抗氧化剂 ,和透皮吸收促进剂。 另外,本发明提供一种透皮吸收制剂,其含有含药物粘合剂层,药物保护层和剥离层,其中含药物粘合剂层含有罗匹尼罗或其盐,丙烯酸橡胶,抗结晶 剂和透皮吸收促进剂。 当本发明的透皮吸收制剂用于治疗帕金森病或不宁腿综合征时,不会出现由于血液中初始药物浓度增加而产生的副作用,并且该药物的皮肤渗透效果极好。